Results 311 to 320 of about 3,841,835 (347)

Drug repurposing in oncology

The Lancet Oncology, 2020
Gauthier, Bouche, Craig, Gedye, Lydie, Meheus, Pan, Pantziarka   +3 more
openaire   +4 more sources

Antibody–drug conjugates: Smart chemotherapy delivery across tumor histologies

Ca-A Cancer Journal for Clinicians, 2022
Paolo Tarantino, Roberto Carmagnani Pestana, Shanu Modi   +2 more
exaly  

Drug repurposing for respiratory infections

Respiratory infections such as Coronavirus disease 2019 are a substantial worldwide health challenge, frequently resulting in severe sickness and death, especially in susceptible groups. Conventional drug development for respiratory infections faces obstacles such as extended timescales, substantial expenses, and the rise of resistance to current ...
Juveriya, Israr, Shabroz, Alam, Ajay, Kumar   +2 more
openaire   +2 more sources

Drug repurposing for neurodegenerative diseases

Neurodegenerative diseases (NDDs) are neuronal problems that include the brain and spinal cord and result in loss of sensory and motor dysfunction. Common NDDs include Alzheimer's disease (AD), Parkinson's disease (PD), Huntington's disease (HD), Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS) etc.
Halak, Shukla, Diana, John, Shuvomoy, Banerjee, Anand Krishna, Tiwari   +3 more
openaire   +2 more sources

Drug repurposing for personalized medicine

Personalized medicine has emerged as a revolutionary approach to healthcare in the 21st century. By understanding a patient's unique genetic and biological characteristics, it aims to tailor treatments specifically to the individual. This approach takes into account factors such as an individual's lifestyle, genetic makeup, and environmental factors to
Jahnvi, Hora, Nishita, Rambhia, Indra, Mani   +2 more
openaire   +2 more sources

Drug Repurposing

2023
openaire   +1 more source

Cancer epigenetics in clinical practice

Ca-A Cancer Journal for Clinicians, 2023
Veronica Davalos, Manel Esteller
exaly  

Drug repurposing for fungal infections

The rise of multidrug-resistant bacteria is a well-recognized threat to world health, necessitating the implementation of effective treatments. This issue has been identified as a top priority on the global agenda by the World Health Organization. Certain strains, such as Candida glabrata, Candida krusei, Candida lusitaniae, Candida auris, select ...
Anshu, Mathuria, Namra, Ali, Naina, Kataria, Indra, Mani   +3 more
openaire   +2 more sources

Computational drug repurposing: approaches, evaluation of in silico resources and case studies

Nature reviews. Drug discovery
Ziaurrehman Tanoli, A. Fernández-Torras, Umut Onur Özcan, Aleksandr Kushnir, Kristen Nader, Yojana Gadiya, Laura Fiorenza, A. Ianevski, Markus Vähä-Koskela, Mitro Miihkinen, Umair Seemab, Henri Leinonen, B. Seashore-Ludlow, Marianna Tampere, Adelinn Kalman, Flavio Ballante, Emilio Benfenati, Gary Saunders, S. Potdar, Ismael Gómez García, Ricard García-Serna, Carmine Talarico, A. Beccari, Wesley Schaal, Andrea Polo, S. Costantini, Enrico Cabri, Marc Jacobs, J. Saarela, Alfredo Budillon, O. Spjuth, P. Östling, Henri Xhaard, Jordi Quintana, Jordi Mestres, P. Gribbon, A. Ussi, Donald C Lo, Martin de Kort, K. Wennerberg, Maddalena Fratelli, Jordi Carreras-Puigvert, T. Aittokallio   +42 more
semanticscholar   +1 more source

Treatment of muscle‐invasive and advanced bladder cancer in 2020

Ca-A Cancer Journal for Clinicians, 2020
Vaibhav G Patel, William K Oh, Matthew D Galsky   +2 more
exaly